The Latest
Visa Partners Singapore Tourism Board to Strengthen Singapore's Global Destination Appeal

Visa Partners Singapore Tourism Board to Strengthen Singapore's Global Destination Appeal

SINGAPORE, Oct. 23, 2026 /PRNewswire/ — Visa, a global leader in digital…
  • October 23, 2026
California Waste Solutions Leads Youth Education, Worker Programs & Government Delegations As Founder David Duong Says He Will Continue "Reinvesting" In Vietnam

California Waste Solutions Leads Youth Education, Worker Programs & Government Delegations As Founder David Duong Says He Will Continue "Reinvesting" In Vietnam

David Duong supports environmental education for young people in Vietnam while workers…
  • October 23, 2026
Getac's Next Generation B360X and B360X Pro Fully Rugged Notebooks Bring the Power of Edge AI to Frontline Professionals

Getac's Next Generation B360X and B360X Pro Fully Rugged Notebooks Bring the Power of Edge AI to Frontline Professionals

Latest additions to Getac’s flagship B360 lineup boast advanced Intel® Core™ Ultra Series…
  • October 23, 2026
Anchanto Partners with JINGDONG Logistics to Help South Korean Brands Sell Across Global Marketplaces

Anchanto Partners with JINGDONG Logistics to Help South Korean Brands Sell Across Global Marketplaces

JINGDONG Logistics will onboard customers through Anchanto’s Operations Experience (OXM) platform, connecting…
  • October 23, 2026

Carnyx Therapeutics Unveils Oral Sleep Candidate CNYX-005 with Preclinical Data Showing Increased NREM Sleep

Preclinical study shows 1.5- to 2-hour increase in total sleep time as…
  • October 23, 2026

Ascletis' Strategic Partner Sagimet Announces First Patient Dosed in Phase III U.S. Clinical Trial of Denifanstat (ASC40) for Moderate to Severe Acne

– With first patient dosed in Phase III clinical trial, Ascletis’ strategic…
  • October 23, 2026

Scage Future Announces Effective Date for ADS Ratio Change

NANJING, China, Oct. 23, 2026 /PRNewswire/ — Scage Future ("Scage Future" or…
  • October 23, 2026

Harbour BioMed Receives China NMPA Approval of Batoclimab Injection (Subcutaneous Injection) for the Treatment of Generalized Myasthenia Gravis

The first NMPA-approved anti-FcRn therapy to complete its full clinical development for…
  • October 23, 2026